ARENA PAUL R 5
5 · PARALLAX HEALTH SCIENCES, INC. · Filed Jan 15, 2019
Insider Transaction Report
Form 5
ARENA PAUL R
DirectorPresident, CEO
Transactions
- Award
PREFERRED STOCK (SERIES C)
2018-09-30$5.00/sh+30,000$150,000→ 5,030,000 totalExercise: $0.12From: 2018-09-30Exp: 2021-09-30→ COMMON STOCK (1,250,000 underlying) - Award
WARRANTS
2018-09-30+15,000→ 5,045,000 totalExercise: $0.25From: 2018-09-30Exp: 2021-09-30→ COMMON STOCK (625,000 underlying)
Footnotes (2)
- [F1]Shares issued in exchange for $150,000 in outstanding debt owed by PRLX
- [F2]Warrants granted in connection with Series C Preferred Shares at 50%